Heparanase is involved in the proliferation and invasion of nasopharyngeal carcinoma cells

Oncology Reports

Volumn 29, Issue 5, 2013, Pages 1888-1894

  Chen, Jinzhang ^a   Zheng, Dayong ^a   Shen, Jie ^a   Ruan, Jian ^a   Li, Aimin ^a   Li, Wenmin ^a   Xie, Guozhu ^a   Luo, Xiaojun ^a   Zhao, Peng ^b   Zheng, Hang ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Heparanase; Invasion; Nasopharyngeal carcinoma; Proliferation

Indexed keywords

HEPARANASE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; SHORT HAIRPIN RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CANCER INVASION; CANCER RESEARCH; CARCINOGENESIS; CARCINOMA CELL; CELL ACTIVITY; CELL CULTURE; CELL INVASION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME REGULATION; ENZYME REPRESSION; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INTRACELLULAR SIGNALING; MALIGNANT TRANSFORMATION; MOUSE; NASOPHARYNX CARCINOMA; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS REGULATION; PROTEIN TARGETING; RNA INTERFERENCE; TUMOR XENOGRAFT;

ANIMALS; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CELL MOVEMENT; DOWN-REGULATION; GLUCURONIDASE; HUMANS; MICE; MICE, NUDE; MITOGEN-ACTIVATED PROTEIN KINASES; NASOPHARYNGEAL NEOPLASMS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; RNA, MESSENGER;

EID: 84876250922     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2013.2325     Document Type: Article

References (32)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin 61: 69-90, 2011.
2. Wei WI and Sham JS: Nasopharyngeal carcinoma. Lancet 365: 2041-2054, 2005. (Pubitemid 40812341)
3. Sanderson RD, Yang Y, Suva LJ and Kelly T: Heparan sulfate proteoglycans and heparanase - partners in osteolytic tumor growth and metastasis. Matrix Biol 23: 341-352, 2004. (Pubitemid 39469549)
4. Simizu S, Ishida K and Osada H: Heparanase as a molecular target of cancer chemotherapy. Cancer Sci 95: 553-558, 2004. (Pubitemid 39089634)
5. Edovitsky E, Elkin M, Zcharia E, Peretz T and Vlodavsky I: Heparanase gene silencing, tumor invasiveness, angiogenesis, and metastasis. J Natl Cancer Inst 96: 1219-1230, 2004. (Pubitemid 39232713)
6. Zheng L, Jiang G, Mei H, et al: Small RNA interference-mediated gene silencing of heparanase abolishes the invasion, metastasis and angiogenesis of gastric cancer cells. BMC Cancer 10: 33, 2010.
7. Lerner I, Baraz L, Pikarsky E, et al: Function of heparanase in prostate tumorigenesis: potential for therapy. Clin Cancer Res 14: 668-676, 2008. (Pubitemid 351231146)
8. Bar-Sela G, Kaplan-Cohen V, Ilan N, Vlodavsky I and Ben-Izhak O: Heparanase expression in nasopharyngeal carcinoma inversely correlates with patient survival. Histopathology 49: 188-193, 2006. (Pubitemid 44079702)
9. Ogren S and Lindahl U: Cleavage of macromolecular heparin by an enzyme from mouse mastocytoma. J Biol Chem 250: 2690-2697, 1975.
10. Nakajima M, Irimura T, Di Ferrante D, Di Ferrante N and Nicolson GL: Heparan sulfate degradation: relation to tumor invasive and metastatic properties of mouse B16 melanoma sublines. Science 220: 611-613, 1983. (Pubitemid 13130144)
11. Vlodavsky I, Fuks Z, Bar-Ner M, Ariav Y and Schirrmacher V: Lymphoma cell-mediated degradation of sulfated proteoglycans in the subendothelial extracellular matrix: relationship to tumor cell metastasis. Cancer Res 43: 2704-2711, 1983. (Pubitemid 13100536)
12. Ilan N, Elkin M and Vlodavsky I: Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis. Int J Biochem Cell Biol 38: 2018-2039, 2006. (Pubitemid 44397619)
13. Vreys V and David G: Mammalian heparanase: what is the message? J Cell Mol Med 11: 427-452, 2007. (Pubitemid 47153456)
14. Zhao W, Wang XS, Niu HT, Wang LL, Han BM and Xia SJ: Clinical relevance of heparanase mRNA expression in bladder cancer and its usefulness as a detection marker in voided urine. Mol Med Rep 2: 327-331, 2009.
15. Nobuhisa T, Naomoto Y, Ohkawa T, et al: Heparanase expression correlates with malignant potential in human colon cancer. J Cancer Res Clin Oncol 131: 229-237, 2005. (Pubitemid 40238939)
16. Chen JQ, Zhan WH, He YL, et al: Relationship between heparanase mRNA expression in human gastric cancer and its clinicopathological features. Zhonghua Zhong Liu Za Zhi 26: 609-611, 2004 (In Chinese).
17. Theodoro TR, de Matos LL, Sant AA, et al: Heparanase expression in circulating lymphocytes of breast cancer patients depends on the presence of the primary tumor and/or systemic metastasis. Neoplasia 9: 504-510, 2007. (Pubitemid 46983453)
18. Leiser Y, Abu-El-Naaj I, Sabo E, et al: Prognostic value of heparanase expression and cellular localization in oral cancer. Head Neck 33: 871-877, 2011.
19. Brun R, Naroditsky I, Waterman M, et al: Heparanase expression by Barrett's epithelium and during esophageal carcinoma progression. Mod Pathol 22: 1548-1554, 2009.
20. Quiros RM, Rao G, Plate J, et al: Elevated serum heparanase-1 levels in patients with pancreatic carcinoma are associated with poor survival. Cancer 106: 532-540, 2006. (Pubitemid 43157615)
21. Hong X, Nelson KK, DeCarvalho AC and Kalkanis SN: Heparanase expression of glioma in human and animal models. J Neurosurg 113: 261-269, 2010.
22. Kelly T, Miao HQ, Yang Y, et al: High heparanase activity in multiple myeloma is associated with elevated microvessel density. Cancer Res 63: 8749-8756, 2003. (Pubitemid 38064053)
23. Bitan M, Polliack A, Zecchina G, et al: Heparanase expression in human leukemias is restricted to acute myeloid leukemias. Exp Hematol 30: 34-41, 2002. (Pubitemid 34059215)
24. Nakajima M, DeChavigny A, Johnson CE, Hamada J, Stein CA and Nicolson GL: Suramin. A potent inhibitor of melanoma heparanase and invasion. J Biol Chem 266: 9661-9666, 1991. (Pubitemid 21906707)
25. Miao HQ, Liu H, Navarro E, Kussie P and Zhu Z: Development of heparanase inhibitors for anti-cancer therapy. Curr Med Chem 13: 2101-2111, 2006. (Pubitemid 44132602)
26. Miao HQ, Elkin M, Aingorn E, Ishai-Michaeli R, Stein CA and Vlodavsky I: Inhibition of heparanase activity and tumor metastasis by laminarin sulfate and synthetic phosphorothioate oligodeoxynucleotides. Int J Cancer 83: 424-431, 1999. (Pubitemid 29455768)
27. Karoli T, Liu L, Fairweather JK, et al: Synthesis, biological activity, and preliminary pharmacokinetic evaluation of analogues of a phosphosulfomannan angiogenesis inhibitor (PI-88). J Med Chem 48: 8229-8236, 2005. (Pubitemid 43032531)
28. Fjose A, Ellingsen S, Wargelius A and Seo HC: RNA interference: mechanisms and applications. Biotechnol Annu Rev 7: 31-57, 2001. (Pubitemid 41081524)
29. Zhang ZH, Chen Y, Zhao HJ, Xie CY, Ding J and Hou YT: Silencing of heparanase by siRNA inhibits tumor metastasis and angiogenesis of human breast cancer in vitro and in vivo. Cancer Biol Ther 6: 587-595, 2007. (Pubitemid 47328334)
30. Zhang Y, Li L, Wang Y, et al: Downregulating the expression of heparanase inhibits the invasion, angiogenesis and metastasis of human hepatocellular carcinoma. Biochem Biophys Res Commun 358: 124-129, 2007. (Pubitemid 46719090)
31. Jiang G, Zheng L, Pu J, et al: Small RNAs targeting transcription start site induce heparanase silencing through interference with transcription initiation in human cancer cells. PLoS One 7: e31379, 2012.
32. De Luca A, Maiello MR, D'Alessio A, Pergameno M and Normanno N: The RAS/RAF/MEK/ERK and the PI3K/AKT signalling pathways: role in cancer pathogenesis and implications for therapeutic approaches. Expert Opin Ther Targets 16 (Suppl 2): S17-S27, 2012.